Zanidatamab (Anti-ERBB2 / HER2 / CD340) | HER2 | Read Reviews & Product Use Citations

Zanidatamab (Anti-ERBB2 / HER2 / CD340) is a humanised, bispecific monoclonal antibody targeting 2 distinct HER2 epitopes (ECD2 and ECD4). It has anti-tumour activity and can be used in treatment of HER2-positive breast and gastric cancer. MW :144.96 KD.

Purity & Quality Control

≥99

Choose Selective HER2 Inhibitors

Biological Activity

Description	Zanidatamab (Anti-ERBB2 / HER2 / CD340) is a humanised, bispecific monoclonal antibody targeting 2 distinct HER2 epitopes (ECD2 and ECD4). It has anti-tumour activity and can be used in treatment of HER2-positive breast and gastric cancer. MW :144.96 KD.

References
[1] Bernstam FM, et al. Lancet Oncol. 2022 Dec;23(12):1558-1570.

References

[1] Bernstam FM, et al. Lancet Oncol. 2022 Dec;23(12):1558-1570.

Product Details

CAS No.	2169946-15-8
Molecular Weight	144.96
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field